首页>
外国专利>
Methods of determining sensitivity of tumor cell growth inhibition by an inhibitor of the kinase of EGFR.Identification of a cancer patient who is likely to benefit from treatment with an inhibitor of EFGR, treatment of cancer in a patient.The selection of a therapy for a patient with cancer and determination of overexpression of ERBB2 gene in a cell.
Methods of determining sensitivity of tumor cell growth inhibition by an inhibitor of the kinase of EGFR.Identification of a cancer patient who is likely to benefit from treatment with an inhibitor of EFGR, treatment of cancer in a patient.The selection of a therapy for a patient with cancer and determination of overexpression of ERBB2 gene in a cell.
The present invention provides methods of predicting response to a cancer therapy based on the methylation status of the ERBB2 gene. One aspect of the invention provides a method of predicting response to an EGFR inhibitor therapy based on the methylation status of the ERBB2 gene.
展开▼
